Find Icosapent Ethyl manufacturers, exporters & distributors on PharmaCompass

Icosapent Ethyl

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 25 USDMF, 8 JDMF, 1 KDMF, 8 Listed Suppliers, $ API Reference Price

30 API Suppliers
25 USDMF
8 JDMF
1 KDMF
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

49 Drugs in Development

49 Drugs in Development

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers, 18 FDA Orange Book, 2 Europe, 1 Canada, 6 Listed Dossiers

27 FDF Dossiers
18 FDA Orange Book
2 Europe
1 Canada
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Evonik, 3 Rochem International Inc, 2 SPI Pharma, 9 DKSH, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 1 Bioplus Life Sciences, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Kerry, 3 Lonza Capsugel, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 6 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

14 Parenteral, 14 Film Formers & Plasticizers, 14 Solubilizers, 13 Fillers, Diluents & Binders, 12 Taste Masking, 12 Coating Systems & Additives, 11 Thickeners and Stabilizers, 9 Topical, 8 Empty Capsules, 7 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Direct Compression, 4 Controlled & Modified Release, 3 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Coloring Agents, 2 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Lubricants & Glidants, 1 Soft Gelatin, 1 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 155 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
155 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices

globalSalesInformation
1 US Medicaid Prescriptions
2 Finished Drug Prices

MARKET PLACE

21 APIs

marketPlace
21 APIs

PATENTS & EXCLUSIVITIES

129 US Patents

patents
129 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM , 1 USP , 2 JP , 2 Others

otherSolutions
1 EDQM
1 USP
2 JP
2 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 240

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

49DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

129

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

155

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

172,833,408

Annual Reports (USD Million)

Finished Drug Prices

85 RELATED EXCIPIENT COMPANIES

144EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Timnodonic acid, Icosapent, 10417-94-4, Icosapentaenoic acid, Epa, Cis-5,8,11,14,17-eicosapentaenoic acid

Molecular Formula

C₂₀H₃₀O₂

Molecular Weight

302.5 g/mol

InChI Key

JAZBEHYOTPTENJ-JLNKQSITSA-N

FDA UNII

AAN7QOV9EA

Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.

1 2D Structure

Icosapent Ethyl

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid

2.1.2 InChI

InChI=1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-

2.1.3 InChI Key

JAZBEHYOTPTENJ-JLNKQSITSA-N

2.1.4 Canonical SMILES

CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O

2.1.5 Isomeric SMILES

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O

2.2 Other Identifiers

2.2.1 UNII

AAN7QOV9EA

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 5,8,11,14,17-eicosapentaenoic Acid

2. 5,8,11,14,17-icosapentaenoic Acid

3. Acid, Eicosapentanoic

4. Eicosapentanoic Acid

5. Icosapent

6. Omega 3 Eicosapentaenoic Acid

7. Omega-3-eicosapentaenoic Acid

8. Timnodonic Acid

2.3.2 Depositor-Supplied Synonyms

1. Timnodonic Acid

2. Icosapent

3. 10417-94-4

4. Icosapentaenoic Acid

5. Epa

6. Cis-5,8,11,14,17-eicosapentaenoic Acid

7. (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoic Acid

8. Icosapento

9. Icosapentum

10. 5,8,11,14,17-eicosapentaenoic Acid

11. Eicosapentaenoate

12. 5z,8z,11z,14z,17z-eicosapentaenoic Acid

13. (all-z)-5,8,11,14,17-eicosapentaenoic Acid

14. Icosapent [inn]

15. (5z,8z,11z,14z,17z)-5,8,11,14,17-eicosapentaenoic Acid

16. 5,8,11,14,17-icosapentaenoic Acid

17. Ropufa 70

18. Ccris 3279

19. Incromega E 7010sr

20. Aan7qov9ea

21. (5z,8z,11z,14z,17z)-icosapentaenoic Acid

22. (5z,8z,11z,14z,17z)-eicosapentaenoic Acid

23. Omega-3-carboxylic Acids

24. Epa 45g

25. Chembl460026

26. (5z,8z,11z,14z,17z)-eicosapentaenoate

27. All-cis-5,8,11,14,17-icosapentaenoic Acid

28. Chebi:28364

29. All-cis-5,8,11,14,17-eicosapentaenoic Acid

30. All-cis-icosa-5,8,11,14,17-pentaenoic Acid

31. Icosapent (inn)

32. Cis-delta(5,8,11,14,17)-eicosapentaenoic Acid

33. 5,8,11,14,17-eicosapentaenoic Acid, (all-z)-

34. All-cis-fatty Acid 20:5 Omega-3

35. Eicosapentaenoic Acid (c20:5 N3)

36. Epa;timnodonic Acid

37. Icosapentaenoate

38. (all-z)-delta5,8,11,14,17-eicosapentaenoic Acid

39. C20:5n-3,6,9,12,15

40. Cis-5,8,11,14,17-epa

41. Fa 20:5

42. Ncgc00161344-03

43. C20:5 (n-3)

44. Eicosapentaenoic Acid (20:5 N-3)

45. Eicosa-5z,8z,11z,14z,17z-pentaenoic Acid (20:5, N-3)

46. Miraxion

47. Eicosapentanoic Acid

48. Eye Q

49. Eye-q

50. 5,8,11,14,17-eicosapentaenoic Acid, (5z,8z,11z,14z,17z)-

51. Epa [drug]

52. Unii-aan7qov9ea

53. 1553-41-9

54. Icosapentum [inn-latin]

55. Icosapento [inn-spanish]

56. (5z,8z,11z,14z,17z)-icosapentaenoate

57. Timnodonate

58. 3gwx

59. All Cis-5,8,11,14,17-eicosapentaenoic Acid

60. Mfcd00065716

61. All-cis-icosapentaenoate

62. All-cis-icosapentaenoic Acid

63. Dsstox_cid_21023

64. Dsstox_rid_79612

65. Dsstox_gsid_41023

66. Schembl20469

67. Bspbio_001328

68. Bml3-b01

69. Gtpl3362

70. Dtxsid9041023

71. Eicosapentaenoic Acid [mi]

72. Hms1361c10

73. Hms1791c10

74. Hms1989c10

75. Hms3402c10

76. Hms3649d19

77. Hy-b0660

78. Zinc4474603

79. 5,8,11,14,17-icosapentaenoate

80. Eicosapentaenoic Acid [inci]

81. Tox21_111991

82. 5,8,11,14,17-eicosapentaenoate

83. Bdbm50242349

84. Eicosapentaenoic Acid [vandf]

85. Lmfa01030759

86. S6476

87. Eicosapentaenoic Acid [mart.]

88. Akos027470327

89. Eicosapentaenoic Acid [usp-rs]

90. Eicosapentaenoic Acid [who-dd]

91. Ccg-207957

92. Ccg-208136

93. Db00159

94. Cis-5,8,11,14,17-eicosapentaenoate

95. Idi1_033798

96. Ncgc00161344-01

97. Ncgc00161344-02

98. Ncgc00161344-04

99. Ncgc00161344-07

100. 5z,8z,11z,14z,17z-eicosapentaenoate

101. Ac-31072

102. As-53730

103. Cas-10417-94-4

104. E0441

105. 5,8,11,14,17-eicosapentaenoic Acid (6ci)

106. All Cis-5,8,11,14,17-icosapentaenoic Acid

107. C06428

108. D08061

109. P16966

110. (all-cis)-5,8,11,14,17-eicosapentaenoic Acid

111. Eicosapentaenoic Acid (epa) (c20:5 N3)

112. L001256

113. Q409990

114. Sr-01000946647

115. Fa(20:5(5z,8z,11z,14z,17z))

116. J-001125

117. Sr-01000946647-1

118. Z,z,z,z,z-eicosa-5,8,11,14,17-pentaenoic Acid

119. (z,z,z,z,z)-5,8,11,14,17-eicosapentaenoic Acid

120. Brd-k47192521-001-02-1

121. Cis-5,8,11,14,17-eicosapentaenoic Acid, >=99%

122. 7f8bf016-b146-4f72-a52e-b9298ba3a9ab

123. C20h30o2 (cis-5,8,11,14,17-eicosapentaenoic Acid)

124. Eicosapentaenoic Acid, 5,8,11,14,17-(z,z,z,z,z)-

125. 5,8,11,14,17-eicosapentaenoic Acid, (all-z)- (8ci)

126. Cis-5,8,11,14,17-eicosapentaenoic Acid, >=85%, Liquid

127. Cis-5,8,11,14,17-eicosapentaenoic Acid, Analytical Standard

128. (5z,8z,11 Z,14z,17z)-icosa-5,8,11,14,17-pentaenoic Acid

129. (5z,8z,11z,14z,17z)-eicosa-5,8,11,14,17-pentaenoic Acid

130. Cis, Cis, Cis, Cis, Cis-eicosa-5,8,11,14,17-pentaenoic Acid

131. 5,8,11,14,17-eicosapentaenoic Acid, (5z,8z,11z,14z,17z)- (9ci)

132. Eicosapentaenoic Acid (epa) (c20:5) (constituent Of Krill Oil) [dsc]

133. Cis-5,8,11,14,17-eicosapentaenoic Acid, 500 Mug/ml In Ethanol, Certified Reference Material

2.4 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₃₀O₂
Molecular Weight	302.5 g/mol
XLogP3	5.6
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	13
Exact Mass	302.224580195 g/mol
Monoisotopic Mass	302.224580195 g/mol
Topological Polar Surface Area	37.3 Å²
Heavy Atom Count	22
Formal Charge	0
Complexity	398
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	5
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

EPA can be used for lowering elevated triglycerides in those who are hyperglyceridemic. In addition, EPA may play a therapeutic role in patients with cystic fibrosis by reducing disease severity and may play a similar role in type 2 diabetics in slowing the progression of diabetic nephropathy.

FDA Label

OM3-CA is indicated as an adjunct to diet to reduce triglycerides levels in adults patients with severe hypertriglyceridemia (>500 mg/dL). The patients involved in this treatment should be laced with an appropriate lipid-lowering diet. Hypertriglyceridemia is defined as an elevated plasma triglyceride concentration. It is usually correlated to other secondary conditions such as poor diet, alcohol use, obesity, metabolic syndrome and type 2 diabetes.

FDA Label

Treatment of Familial Adenomatous Polyposis

Treatment of dyslipidaemia

5 Pharmacology and Biochemistry

5.1 Pharmacology

Eicosanoids are chemical messengers derived from 20-carbon polyunsaturated fatty acids that play critical roles in immune and inflammatory responses. Both 20-carbon omega-6 fatty acids (arachidonic acid) and 20-carbon omega-3 fatty acids (EPA) can be found in cell membranes. During an inflammatory response, arachidonic acid and EPA are metabolized by enzymes known as cyclooxygenases and lipoxygenases to form eicosanoids. Increasing omega-3 fatty acid intake increases the EPA content of cell membranes and decreases the arachidonic acid content, resulting in higher proportions of eicosanoids derived from EPA. Physiologic responses to arachidonic acid-derived eicosanoids differ from responses to EPA-derived eicosanoids. In general, eicosanoids derived from EPA are less potent inducers of inflammation, blood vessel constriction, and clotting than eicosanoids derived from arachidonic acid.

OM3-CA is very effective in reducing triglyceride levels. After 14 days of treatment, it is possible to observe even a 21% reduction. The reduction of the triglycerides could reach even to 25% in cases with the maximal used concentration of 4 g.

5.2 Absorption, Distribution and Excretion

Absorption

When compared to omega-3 -acid ethyl esters, OM3-CA present a 4-fold higher bioavailability. OM3-CA is absorbed directly in the small intestine and the maximal plasma concentration is reached between 4.5-5 hours after initial administration. The absorbed dosage is transferred to the general circulation via the lymphatic system and distributed within tissues throughout the body. The absorption speed and extent is highly promoted by the bile. In preclinical studies performed in dogs, the Cmax, tmax and AUC were reported to be 15.1 mcg/ml, 24 hours and 1210.3 mcg.h/ml, respectively.

Route of Elimination

OM3-CA does not go under renal excretion. After the metabolism, all the dose is excreted as CO2 and water in the form of expelled air and the rest is excreted in feces.

Volume of Distribution

This pharmacokinetic property is not available.

Clearance

The registered clearance rate at steady-state is of 548 ml/h for eicosapentaenoic acid and 518 ml/h for docohexaenoic acid.

5.3 Metabolism/Metabolites

OM3-CA is metabolized in the liver following the normal fatty acid oxidation. Once absorbed, they are incorporated into triglycerides, cholesterol esters and phospholipids in tissues. The metabolism is marked by beta-oxidation followed by tricarboxylic acid cycle. It is reported that OM3-CA is an inhibitor of several enzymes such as CYP2C9, CYP2C19 and to a lesser extent to CYP1A2, CYP2E1, CYP3A4. It is thought that the metabolism of OM3-CA is mainly done by CYP3A and CYP4F3B.

Eicosapentaenoic acid has known human metabolites that include Juniperonic acid.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560

5.4 Biological Half-Life

The half-life of OM3-CA depends on the type of component in which for eicosapentaenoic acid it is estimated to be of approximately 4.7-10.8 hours while for docosahexaenoic acid is reported to be of about 7 hours. The half-life of baseline-adjusted at steady-state is of 36 and 46 hours respectively for eicosapentaenoic acid and docosahexaenoic acid.

5.5 Mechanism of Action

The anti-inflammatory, antithrombotic and immunomodulatory actions of EPA is probably due to its role in eicosanoid physiology and biochemistry. Most eicosanoids are produced by the metabolism of omega-3 fatty acids, specifically, arachidonic acid. These eicosanoids, leukotriene B4 (LTB4) and thromboxane A2 (TXA2) stimulate leukocyte chemotaxis, platelet aggregation and vasoconstriction. They are thrombogenic and artherogenic. On the other hand, EPA is metabolized to leukotriene B5 (LTB5) and thromboxane A3 (TXA3), which are eicosanoids that promote vasodilation, inhibit platelet aggregation and leukocyte chemotaxis and are anti-artherogenic and anti-thrombotic. The triglyceride-lowering effect of EPA results from inhibition of lipogenesis and stimulation of fatty acid oxidation. Fatty acid oxidation of EPA occurs mainly in the mitochondria. EPA is a substrate for Prostaglandin-endoperoxide synthase 1 and 2. It also appears to affect the function and bind to the Carbohydrate responsive element binding protein (ChREBP) and to a fatty acid receptor (G-coupled receptor) known as GP40.

The reduction of the synthesis of triglycerides in the liver may be caused because the main components of OM3-CA, eicosapentaenoic acid, and docosahexaenoic acid, are poor substrates for the enzymes responsible for the synthesis of triglycerides. These two major components inhibit the esterification of other fatty acids. OM3-CA is also thought to enhance the clearance of triglycerides from the circulating very low-density lipoprotein particles by different potential effects such as inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase, increase in mitochondrial and peroxisomal beta-oxidation in the liver, decrease lipogenesis in the liver and increase lipoprotein lipase activity.

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

01

AK BIOPHARM CO. , LTD.

South Korea

Antibody Engineering

Not Confirmed

02

BASF Pharma (Callanish) Ltd.

Germany

Antibody Engineering

Not Confirmed

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

01

Chemport Inc

United Kingdom

Antibody Engineering

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

Axplora

Germany

Antibody Engineering

Not Confirmed

Axplora- The partner of choice for complex APIs.

Contact Supplier

Germany

Virtual Booth

Digital Content

Icosapent Ethyl

About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...

Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-quality APIs on time & at scale, to the highest industry standards. It is dedicated to helping pharma companies make critical medicines safely to benefit patients. Leveraging our combined expertise & manufacturing capabilities across 9 industrial sites in the EU & India & an R&D facility in the USA, it offers CDMO services for small molecule APIs & biopharmaceuticals to innovators as well as APIs that address lifestyle-induced respiratory, inflammatory & liver diseases.

02

DKSH

Switzerland

Antibody Engineering

Not Confirmed

DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Contact Supplier

Switzerland

Virtual Booth

Digital Content

Icosapent Ethyl

About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...

DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.

03

Chunghwa Chemical Synthesis & Biote...

Taiwan

Antibody Engineering

Not Confirmed

Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

Contact Supplier

Taiwan

Virtual Booth

Digital Content

Eicosapentaenoic Acid

About the Company : Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast...

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast Asia to receive FDA approval for synthetic and biotech APIs, CCSB has a proven track record of commercializing Statin, Immunosuppressant, Muscle Relaxant, and ACE Inhibitor APIs, all with complete DMF or COS. For years, CCSB has partnered with leading brand and generic drug companies to develop and produce APIs and advanced intermediates, focusing on specialty APIs crafted through a sophisticated fusion of fermentation and synthesis technologies in Taiwan.

04

Chunghwa Chemical Synthesis & Biote...

Taiwan

Antibody Engineering

Not Confirmed

Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

Contact Supplier

Taiwan

Virtual Booth

Digital Content

Icosapent Ethyl

05

BASF

Antibody Engineering

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648060200,"product":"PHARMACEUTICAL RAW MATERIAL ICOSAPENT ET","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ALEXANDRIA, EL NHOUZ","customer":"LIFOPHMEPR","customerCountry":"EGYPT","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"400","totalValueFC":"669.1","currency":"USD","unitRateINR":25500,"date":"24-Mar-2022","totalValueINR":"51000","totalValueInUsd":"669.1","indian_port":"BOMBAY AIR","hs_no":"29161990","bill_no":"9179883","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"ICOSAPENT ETHYL","year":"2021","qtr":"Q1","strtotime":1617042600,"product":"ICOSAPENT ETHYL (FOR TESTING PURPOSE ONLY)","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"HUATAI PHARMA","supplierCountry":"CHINA","foreign_port":"","customer":"CIPLA","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"186","totalValueFC":"562.2","currency":"USD","unitRateINR":"13643.1","date":"30-Mar-2021","totalValueINR":"40929.3","totalValueInUsd":"562.2","indian_port":"BOMBAY AIR","hs_no":"29161950","bill_no":"3358153","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"MUMBAI CENTRAL,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1632076200,"product":"ICOSAPENT ETHYL(BATCH NO: EPA97-210601, EPA97-210602)(QTY 90.2 KGS, USD 14702.60)","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"HUATAI PHARMA","supplierCountry":"CHINA","foreign_port":"#N\/A","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"90.20","actualQuantity":"90.2","unit":"KGS","unitRateFc":"163","totalValueFC":"14871.2","currency":"USD","unitRateINR":"12127.2","date":"20-Sep-2021","totalValueINR":"1093873.44","totalValueInUsd":"14871.2","indian_port":"BANGALORE AIR","hs_no":"29349990","bill_no":"5517305","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"7-1-27, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643221800,"product":"ICOSAPENT ETHYL EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE)(30 KG\/10 KG PER BOTTLE. USD 10500)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"#N\/A","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"350","totalValueFC":"12678.1","currency":"USD","unitRateINR":"31481.2","date":"27-Jan-2022","totalValueINR":"944435.32","totalValueInUsd":"12678.1","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"7250573","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645122600,"product":"ICOSAPENT ETHYL","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"AK & MN BIOFARM","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"250","totalValueFC":"507.3","currency":"USD","unitRateINR":"19012.5","date":"18-Feb-2022","totalValueINR":"38025","totalValueInUsd":"507.3","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"7550011","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656181800,"product":"ICOSAPENT ETHYL","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"AK & MN BIOFARM","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"250","totalValueFC":"1265","currency":"USD","unitRateINR":"19737.5","date":"26-Jun-2022","totalValueINR":"98687.5","totalValueInUsd":"1265","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"9286278","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659637800,"product":"ICOSAPENT ETHYL (EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE))(100 KG\/10 KG PER BOTTLE. USD 35000)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"350","totalValueFC":"42757.6","currency":"USD","unitRateINR":"34021","date":"05-Aug-2022","totalValueINR":"3402098.44","totalValueInUsd":"42757.6","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"9876859","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665513000,"product":"ICOSAPENT ETHYL (EICOSAPENTAENOIC ACID ETHYL ESTER (MAXOMEGATM EPA 96EE)","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"350","totalValueFC":"85","currency":"USD","unitRateINR":"34953.7","date":"12-Oct-2022","totalValueINR":"6990.73","totalValueInUsd":"85","indian_port":"BANGALORE AIR","hs_no":"29163990","bill_no":"2837024","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666031400,"product":"ICOSAPENT ETHYL 97 % - 10 KGS ( FOR R & D PURPOSE ONLY )","address":"ALKEM HOUSE, DEVASHISH ADJACENT T O,MATULYA CENTRE, SENAPATI BAPAT MA","city":"MUMBAI,MAHARASHTRA","supplier":"KINOMEGA BIOPHARM INC.","supplierCountry":"CHINA","foreign_port":"NA","customer":"ALKEM LABORATORIES","customerCountry":"INDIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"180","totalValueFC":"1803.6","currency":"USD","unitRateINR":"14841","date":"18-Oct-2022","totalValueINR":"148410","totalValueInUsd":"1803.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"2927710","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ALKEM HOUSE, DEVASHISH ADJACENT T O,MATULYA CENTRE, SENAPATI BAPAT MA"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676831400,"product":"MAXOMEGA EPA 96 EE 10 KG IP3A (ICOSAPENT ETHYL) FOR EXCIPIENT USE ONLY","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"314.9","totalValueFC":"34871","currency":"USD","unitRateINR":"28800","date":"20-Feb-2023","totalValueINR":"2880000","totalValueInUsd":"34871","indian_port":"HYDERABAD AIR","hs_no":"29161990","bill_no":"4726813","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1682015400,"product":"MAXOMEGA EPA 96 EE 30 KG (ICOSAPENT ETHYL) FOR EXCIPIENT USEONLY","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"BASF","supplierCountry":"UNITED KINGDOM","foreign_port":"NA","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"30.00","actualQuantity":"30","unit":"KGS","unitRateFc":"331.8","totalValueFC":"11758.1","currency":"USD","unitRateINR":"32120.7","date":"21-Apr-2023","totalValueINR":"963620.54","totalValueInUsd":"11758.1","indian_port":"HYDERABAD AIR","hs_no":"29161990","bill_no":"5623223","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1682274600,"product":"ICOSAPENT ETHYL(EPA960EE)","address":"NO.18, GROUND FLOOR, DR. NAIR ROAD,T.NAGAR,","city":"CHENNAI.","supplier":"CHEMPORT INC","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"MADRAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"9.00","actualQuantity":"9","unit":"KGS","unitRateFc":"150","totalValueFC":"1474.3","currency":"USD","unitRateINR":"13424.8","date":"24-Apr-2023","totalValueINR":"120822.76","totalValueInUsd":"1474.3","indian_port":"MADRAS AIR","hs_no":"29420090","bill_no":"5650348","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO.18, GROUND FLOOR, DR. NAIR ROAD,T.NAGAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691605800,"product":"ICOSAPENT ETHYL J.P CAS NO. 86227-47-6 INV NO. BD080423E97D00E0570 DTD. 07.08.2023","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI","supplier":"M S AK MN BIOFARM CO LIMITED","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"570.00","actualQuantity":"570","unit":"KGS","unitRateFc":"150","totalValueFC":"86115.7","currency":"USD","unitRateINR":"12389.8","date":"10-Aug-2023","totalValueINR":"7133504.4","totalValueInUsd":"86115.7","indian_port":"SAHAR AIR","hs_no":"29162090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SOUTH KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693247400,"product":"ICOSAPENT ETHYL J.P. CAS NO. 86227-47-6 DOCUMENT NO. BD080423E97D00E1330 DTD. 08.07.2023","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI","supplier":"M S AK MN BIOFARM CO LIMITED","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1330.00","actualQuantity":"1330","unit":"KGS","unitRateFc":"146","totalValueFC":"196634.1","currency":"USD","unitRateINR":"12124.5","date":"29-Aug-2023","totalValueINR":"16288443.32","totalValueInUsd":"196634.1","indian_port":"JNPT\/ NHAVA SHEVA SEA","hs_no":"29162090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SOUTH KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694629800,"product":"ICOSAPENT ETHYL","address":"206, DEVAVRATA,","city":"NAVI MUMBAI, MAHARASHTRA.","supplier":"HUATAI PHARMA","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"STRIDES PHARMA SCIENCE","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"156","totalValueFC":"6390.7","currency":"USD","unitRateINR":"13262","date":"14-Sep-2023","totalValueINR":"530481.09","totalValueInUsd":"6390.7","indian_port":"Bangalore Air","hs_no":"29420090","bill_no":"7836938","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.37 SECTION 6, NORTH CHENGDU AVENUE, GUANGHAN, DEYANG CITY, SICHUANPROVINCE 618304 P.R CN","customerAddress":"206, DEVAVRATA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707762600,"product":"ICOSAPENT ETHYL 97% (FOR LABORATORY RESEARCH)","address":"IRIS- 1004, KESAR GARDEN, PLOT NO.","city":"NAVI MUMBAI.","supplier":"KINOMEGA BIOPHARM INC.","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"V-ENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"220","totalValueFC":"1112.9","currency":"USD","unitRateINR":"18469","date":"13-Feb-2024","totalValueINR":"92345","totalValueInUsd":"1112.9","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"2120625","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"No.161, South Yinghuashan Road, Shifang, Deyang City, Sichuan, China,618400 China","customerAddress":"IRIS- 1004, KESAR GARDEN, PLOT NO."},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708626600,"product":"ICOSAPENT ETHYL (FOR R&D PURPOSE ONLY)","address":"IRIS- 1004, KESAR GARDEN, PLOT NO.","city":"NAVI MUMBAI.","supplier":"NOVASEP","supplierCountry":"FRANCE","foreign_port":"PARIS - CHARLES DE G","customer":"V-ENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"448","totalValueFC":"2447.2","currency":"EUR","unitRateINR":"40611.2","date":"23-Feb-2024","totalValueINR":"203056","totalValueInUsd":"2447.2","indian_port":"Bombay Air","hs_no":"29161990","bill_no":"2273653","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"PARIS - CHARLES DE G","supplierAddress":"AVENUE DU LAC, F-64150 MOURENXSDNFSDNF France","customerAddress":"IRIS- 1004, KESAR GARDEN, PLOT NO."},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719513000,"product":"ICOSAPENT ETHYL (EPA960EE)FOR TESTING PURPOSE","address":"NO.15, GOPALAKRISHNAN ROAD,","city":"CHENNAI","supplier":"CHEMPORT INC","supplierCountry":"REPUBLIC OF KOREA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MADRAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.83","actualQuantity":"0.83","unit":"KGS","unitRateFc":"150","totalValueFC":"129.5","currency":"USD","unitRateINR":"13029.2","date":"28-Jun-2024","totalValueINR":"10814.26","totalValueInUsd":"129.5","indian_port":"Madras Air","hs_no":"29420090","bill_no":"4234394","productDescription":"API","marketType":"","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"30-5 DONGSUNONGGONGDANJI-GILJEOLLANAM NAJU-SI58275 KR KOREA,REPUBLIC OF","customerAddress":"NO.15, GOPALAKRISHNAN ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721241000,"product":"ETHYL ICOSAPENTATE(ICOSAPENT ETHYL)","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH","supplierCountry":"TAIWAN","foreign_port":"TAIYUAN","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"24.00","actualQuantity":"24","unit":"KGS","unitRateFc":"200","totalValueFC":"5089","currency":"USD","unitRateINR":"17724.9","date":"18-Jul-2024","totalValueINR":"425397.95","totalValueInUsd":"5089","indian_port":"Bombay Air","hs_no":"29153100","bill_no":"4570234","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TAIYUAN","supplierAddress":"CH CO , LTD . 1 TUNG-HSING STREET,SHU-LIN-DIST., NEW TAIPEI CITY 23850, TAIWAN R.O.C TAIWAN TAIWAN","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727116200,"product":"ICOSAPENT ETHYL J.P (INV NO. BD091924E97D00E0570 DTD. 19.09.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"M\/S AK BIOPHARM CO LTD","supplierCountry":"REPUBLIC OF KOREA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"570.00","actualQuantity":"570","unit":"KGS","unitRateFc":"120","totalValueFC":"69052","currency":"USD","unitRateINR":"10152","date":"24-Sep-2024","totalValueINR":"5786640","totalValueInUsd":"69052","indian_port":"Bombay Air","hs_no":"29162090","bill_no":"5778026","productDescription":"API","marketType":"","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"81, SANGGAE-RO, NAM-GU UISAN 44787 REPLUBLIC OF KOREA KR","customerAddress":"407\/408,SHARDA CHAMBERS,"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

Film Formers & Plasticizers

Solubilizers

Fillers, Diluents & Binders

Taste Masking

Coating Systems & Additives

Thickeners and Stabilizers

Topical

Empty Capsules

Emulsifying Agents

Chewable & Orodispersible Aids

Direct Compression

Controlled & Modified Release

Co-Processed Excipients

Disintegrants & Superdisintegrants

Coloring Agents

API Stability Enhancers

Surfactant & Foaming Agents

Lubricants & Glidants

Soft Gelatin

Rheology Modifiers

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USP

01

Japanese Pharmacopoeia

Japan

Antibody Engineering

Not Confirmed

02

Japanese Pharmacopoeia

Japan

Antibody Engineering

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Market Place

Home

Post Enquiry

Market Place

Find Icosapent Ethyl manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers

25 USDMF

8 JDMF

1 KDMF

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

49 Drugs in Development

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers

18 FDA Orange Book

2 Europe

1 Canada

6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Evonik

3 Rochem International Inc

2 SPI Pharma

9 DKSH

1 Pharm-RX Chemical

2 Faran Shimi Pharmaceutical

3 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 BASF

1 Bioplus Life Sciences

1 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Kerry

3 Lonza Capsugel

1 Nanjing Bold Chemical

3 Pluviaendo

1 Qualicaps

14 Roquette

6 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

14 Parenteral

14 Film Formers & Plasticizers

14 Solubilizers

13 Fillers, Diluents & Binders

12 Taste Masking

12 Coating Systems & Additives

11 Thickeners and Stabilizers

9 Topical

8 Empty Capsules

7 Emulsifying Agents

5 Chewable & Orodispersible Aids

4 Direct Compression

4 Controlled & Modified Release

3 Co-Processed Excipients

3 Disintegrants & Superdisintegrants

3 Coloring Agents

2 API Stability Enhancers

2 Surfactant & Foaming Agents

2 Lubricants & Glidants

1 Soft Gelatin

1 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

155 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

2 Finished Drug Prices

MARKET PLACE

21 APIs

PATENTS & EXCLUSIVITIES